Home > Analytics > CAPLIN POINT LABORATORIES

CAPLIN POINT LABORATORIES
Intrinsic Value | Fundamental Analysis

BOM : 524742     NSE : CAPLIPOINT    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Downward
Pledged Shares : None or < 25%
Mar 20,2023
Price(EOD): ₹ 628.45
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 4,769.94 Cr
Value of ₹ 1 Lac invested in CAPLIN POINT LABORATORIES
on Mar 20,2018 (price: ₹ 571.30)

₹ 1 L

₹ 1.10 L

1W : -1.7% 1M : -9.2% 1Y : -16.2%
COMMUNITY POLL
for CAPLIN POINT LABORATORIES
Please provide your vote to see the results
CAPLIN POINT LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Industry Peers & Returns1W1M1Y
CAPLIN POINT LABORATORIES -1.7% -9.2% -16.2%
SUN PHARMACEUTICAL INDUSTRIES 0.4% -3.5% 7.8%
DIVIS LABORATORIES 1.5% -2.7% -36.6%
CIPLA -0.6% -16.3% -17.2%
DR REDDYS LABORATORIES 2.1% -1.7% 12.5%
TORRENT PHARMACEUTICALS 0.1% 0.9% 7.5%
ABBOTT INDIA 4.7% 4.4% 20.6%
ZYDUS LIFESCIENCES 1.1% -0.3% 27.1%
ALKEM LABORATORIES 0.6% -6% -8.9%

FUNDAMENTAL ANALYSIS OF CAPLIN POINT LABORATORIES

 
Fundamentals Score
[ Q(TTM): Dec2022, Y: Mar2022
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 CAPLIPOINT is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF CAPLIN POINT LABORATORIES

 
Valuation Score
[As on : Mar 20,2023 ]

Ratio Consolidated
P/E
P/B
P/S
13.38
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 356.56 Cr
[Latest Qtr - Dec2022 - Consolidated Results ]

3.23
P/B Calculated based on Book Value of Rs 1,474.98 Cr
[Latest Year - Mar2022 - Consolidated Results ]

3.37
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,416.69 Cr
[Latest Qtr - Dec2022 - Consolidated Results ]

Financial Ratios →

Insights 💡 CAPLIPOINT is one of the potential top 31% undervalued companies ! Discover More →

FAIR VALUE OF CAPLIN POINT LABORATORIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
-20%
-39%
-37%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF CAPLIN POINT LABORATORIES



CAPLIN POINT LABORATORIES vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF CAPLIN POINT LABORATORIES

Year Debt/Equity ratio
Standalone Consolidated
2022
2021
2020
Avg_3yrs
0
0
0
-
0
0.01
0.04
0.02
[Last Annual Data : Mar2022]
Financial Ratios →

PLEDGED PROMOTER SHARES OF CAPLIN POINT LABORATORIES

Pledged Promoter Shares
0 %
As on : Dec2022

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF CAPLIN POINT LABORATORIES

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
3.63%
3.59%
1.15%
5.8%
14.06%
8.33%
13.25%
22.83%
QtrlyTrend
8
Latest Qtr: Dec2022
Quarterly Result Analysis →


CAPLIN POINT LABORATORIES related INDICES

BSE Indices1W1M1Y
S&P BSE HEALTHCARE 0.1% -3.4% -9.9%
S&P BSE 500 -1% -4.8% 0.8%
S&P BSE ALLCAP -1% -4.8% 0.8%
S&P BSE 250 SMALLCAP -1.4% -3.1% 0.5%
S&P BSE 400 MIDSMALLCAP -1.4% -3.4% 3.5%
NSE Indices1W1M1Y
NIFTY 500 -1% -4.8% 0.7%
NIFTY500 MULTICAP 50:25:25 -1.1% -4.3% 0.9%
NIFTY MID SMALL400 -1.3% -3.2% 3.5%
NIFTY SMALLCAP250 -1.6% -3.8% -3.2%

You may also like the below Video Courses


FAQ about CAPLIN POINT LABORATORIES


Is CAPLIN POINT LABORATORIES good for long term investment?

As on Mar 20,2023, the Fundamentals of CAPLIN POINT LABORATORIES look Strong and hence it may be good for long term investment! See Financial Performance of CAPLIN POINT LABORATORIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is CAPLIN POINT LABORATORIES UnderValued or OverValued?

As on Mar 20,2023, CAPLIN POINT LABORATORIES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of CAPLIN POINT LABORATORIES ?

As on Mar 20,2023, the Intrinsic Value of CAPLIN POINT LABORATORIES is Rs. 992.67 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 781.69
Fair Value [Median EV / Sales Model] : Rs. 1,025.98
Fair Value [Median Price / Sales Model] : Rs. 992.67
Estimated Median Fair Value of CAPLIN POINT LABORATORIES : Rs. 992.67

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is CAPLIN POINT LABORATORIES trading at a Premium or Discount?

As on Mar 20,2023, CAPLIN POINT LABORATORIES is trading at a Discount of -37% based on the estimates of Median Intrinsic Value!

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].